GSGCX | VIVIX | GSGCX / VIVIX | |
Total Expense Ratio | 1.75 | 0.04 | 4,375% |
Annual Report Gross Expense Ratio | 1.95 | 0.04 | 4,875% |
Fund Existence | 28 years | 27 years | - |
Gain YTD | 7.292 | 6.669 | 109% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 412M | 196B | 0% |
Annual Yield % from dividends | 0.62 | 2.19 | 28% |
Returns for 1 year | 2.04 | 8.04 | 25% |
Returns for 3 years | 11.65 | 26.09 | 45% |
Returns for 5 years | 33.43 | 68.75 | 49% |
Returns for 10 years | 60.16 | 114.89 | 52% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
RKLX | 81.71 | 5.11 | +6.67% |
Defiance Daily Target 2X Long RKLB ETF | |||
CANC | 26.70 | 0.30 | +1.14% |
Tema Oncology ETF | |||
QQQD | 14.51 | 0.07 | +0.50% |
Direxion Daily Concentrated Qs Bear 1X Shares | |||
VRIG | 25.15 | 0.01 | +0.04% |
Invesco Variable Rate Investment Grd ETF | |||
KJAN | 38.69 | -0.04 | -0.10% |
Innovator US Small Cap Pwr Buff ETF™ Jan |